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Abstract
Background:  Life at altitude depends on adaptation to ambient hypoxia. In the Andes,
susceptibility to chronic mountain sickness (CMS), a clinical condition that occurs to native
highlanders or to sea level natives with prolonged residence at high altitude, remains poorly
understood. We hypothesized that hypoxia-associated gene expression in children of men with
CMS might identify markers that predict the development of CMS in adults. We assessed distinct
patterns of gene expression of hypoxia-responsive genes in children of highland Andean men, with
and without CMS.
Methods: We compared molecular signatures in children of highland (HA) men with CMS (n =
10), without CMS (n = 10) and in sea level (SL) children (n = 20). Haemoglobin, haematocrit, and
oxygen saturation were measured. Gene expression in white cells was assessed at HA and then, in
the same subjects, within one hour of arrival at sea level.
Results: HA children showed higher expression levels of genes regulated by HIF (hypoxia inducible
factor) and lower levels of those involved in glycolysis and in the tricarboxilic acid (TCA) cycle.
Pyruvate dehydrogenase kinase 1(PDK1) and HIF prolyl hydroxylase 3 (HPH3) mRNA expressions
were lowest in children of CMS fathers at altitude. At sea level the pattern of gene expression in
the 3 children's groups was indistinguishable.
Conclusion: The molecular signatures of children of CMS patients show impaired adaptation to
hypoxia. At altitude children of CMS fathers had defective coupling between glycolysis and
mitochondria TCA cycle, which may be a key mechanism/biomarker for adult CMS. Early biologic
markers of disease susceptibility in Andeans might impact health services and social planning.
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Background
Human beings are considered hypoxia-sensitive; however,
evidence for different adaptive strategies by various high-
land populations in coping with their hypoxic environ-
ment is abundant. Tibetans, for example, with a longer
history of high altitude residence, seem better adapted
than Andeans. This is implied by different steps in the
oxygen transport cascade [1,2]. Thus, average resting ven-
tilation and arterial oxygen saturation (SaO2) are higher
in Tibetans than in Aymaras and Quechuas of the Andes.
In addition, Tibetans show lower frequency of intrauter-
ine growth retardation, better neonatal oxygenation,
lower pulmonary artery pressure and resistance, and lower
frequency of chronic mountain sickness (CMS); a sudden
loss of adaptation to their highland hypoxic abode
appearing first in men in early midlife and in post-meno-
pausal women [3,4]. In Ethiopians, SaO2 and haemo-
globin values in high altitude residents similar to those of
sea level subjects have also been reported [5]. These pop-
ulations have been residents of the high altitude regions
of the world for different lengths of time [6,7]. Natural
selection may have equipped Tibetans and Ethiopians,
who have resided at altitude for longer times, with molec-
ular adaptations that have not, as yet, made their impact
in the Andes. Moreover, not all subjects within a popula-
tion of highlanders have similar susceptibilities to CMS,
and a tendency to familial clustering of CMS in Andean
populations has also been noted [8-10].
We hypothesized that, CMS patients and their children,
who do not, as yet, have CMS by clinical criteria, may nev-
ertheless, have suggestive molecular signatures that hint at
an inability to cope with the metabolic demands of ambi-
ent hypoxia. This could be discernible in the impaired
transformation of glycolysis-derived pyruvate into Acetyl
CoA for efficient ATP production in mitochondrial TCA
cycle and by the inadequate expression and activity of key
enzymes controlling the coupling between glycolysis and
TCA cycle in the face of hypoxia. Thus in adult CMS
patients and their clinically normal children, the match-
ing of cellular energy demands with efficient ATP produc-
tion, in ambient hypoxia, might be impaired, eventually,
leading to cellular energy "failure" in the patients[11].
This deficiency might already be discernable, to some
extent, at a younger age.
Adaptation to chronic hypoxia in children such as physi-
cal growth, oxygen saturation, haemoglobin concentra-
tion, respiratory rate, and other cardiopulmonary
modifications have been documented. [12-15]. To date
no correlations of phenotypic changes with molecular sig-
natures in children of Andean highlanders have been
reported. Preliminary data from the highlands do suggest,
however, that perinatal exposure to chronic hypoxia
increases susceptibility to the later development of mala-
daptation to life in chronic hypoxia such as CMS. [16]. We
hypothesized that the molecular signatures of children
might serve as biomarkers for the occurrence of CMS in
adulthood.
We focused on oxygen-responsive genes and on those
involved in glycolytic and mitochondrial metabolic path-
ways [17,18].
Methods
Design
A cross-sectional study was performed in three groups;
children of high altitude natives with CMS; children of
high altitude controls, and sea level children without
Andean ancestry. Absence of Andean ancestry was defined
as absence of parents and grandparents native to high alti-
tude. Ten children were recruited in each high altitude
group and 20 in the sea level group. For each adult one
child was studied. The children were matched by age and
sex.
The protocol was approved by the Ethics Committee of
Cayetano Heredia University, Lima, Peru. Before perform-
ing any procedure, a written informed consent was
obtained from parents. Each child also gave separate writ-
ten assent.
Inclusion criteria
Children native to and resident at Cerro de Pasco, aged 5
to 17 years, that did not drink regularly herbal infusions
that might reduce red cell mass were included.
Exclusion criteria
Children with significant acute or chronic clinical condi-
tions or those who had visited altitudes below 2000 m in
the last 3 months were excluded.
Study procedures
High altitude children were studied in Cerro de Pasco first,
and then transferred to Lima. Sea level natives were stud-
ied in Lima.
A clinical history, physical examination, weight and
height measurements, and arterial oxygen saturation
(pulse oximetry, SaO2) were obtained. Information on
relevant current and past diseases, use of cytotoxic drugs
or herbal infusions considered by natives as effective for
reducing polycythaemia, and history of descent to alti-
tudes below 2000 m. were noted.
Blood samples were taken for haemoglobin and haemat-
ocrit determinations, and for RNA assays. Eight milliliters
were drawn from children in Cerro and the same volume
was taken in Lima. Haemoglobin was determined
through spectrophotometry and haematrocrit through aBMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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standard capillary technique. At sea level, blood was taken
from high altitude subjects within 1 hour after arrival to
Lima for gene expression determination.
Determination of gene expression through quantitative 
real-time PCR
For quantitative real-time PCR determination, the total
RNA of white blood cells was extracted through PAXgene
Blood RNA kit (Qiagen, Germany) [11]. In brief, one
microgram of total RNA was reverse transcribed into first-
strand cDNA using the RETROscript reverse transcriptase
kit and oligo dT primers (Ambion, TX), following the
manufacturer's protocols. One microliter of cDNA from
the reverse transcriptase reaction was used as the template
for quantitative real-time PCR reaction with a final PCR
reaction volume of 25 ml, with the 59 and 39 gene specific
PCR primer concentrations at 100 nM each. PCR primers
were designed using Primer3 software (Whitehead Insti-
tute, MIT, Massachusetts, USA) according to the coding
sequences of each gene. Quantification of mRNA expres-
sion was performed by triplicate using the SYBR Green
SuperMix (BioRad, California, USA) and a 2-step PCR
reaction procedure, performed on the MyiQ Single Color
Real-Time PCR Detection System (BioRad, California,
USA). After the initial denaturation at 95°C for 3 minutes,
45 cycles of primer annealing and elongation were con-
ducted at 58°C for 45 seconds, followed by denaturation
at 95°C for 10 seconds. Fluorescent emission data were
captured, and mRNA levels were quantified using the
threshold cycle value. To compensate for variations in
input RNA amounts and efficiency of reverse transcrip-
tion, data for each target gene mRNA of each sample were
normalized by reference to the data obtained for the
house keeping HPRT (GenBank accession number
X62085) determined from the same sample. Each real-
time PCR assay was repeated twice.
Definition and explanation of terms related to gene
expression are detailed as an appendix (See additional file
1).
Data analysis
To assess the impact of specific genes on chronic moun-
tain sickness-score (CMS-sc), using a sliding scale (contin-
uous), we constructed an "impact table" for the combined
(CMS & Controls) Cerro de Pasco groups of fathers at alti-
tude (Cerro de Pasco, 4338 m.) and at sea level (Lima, 150
m.). The impact table was constructed using CMS-sc of the
fathers as a continuous variable and consists of the effect
sizes (standardized beta) for each gene in univariate linear
regression in the first columns, the effect sizes for each
gene adjusting for the best univariate predictor (HPH3 at
both altitudes) in the middle columns, and the residual
effect size of HPH3 adjusting for each of the other genes
in the final columns. The STB is the standardized estimate
for the parameter estimate of an explanatory variable in
the logistic regression model and is computed by multi-
plying the estimate by the sample standard deviation for
the explanatory variable and dividing by π/√ 3. In addi-
tion to the comparison among high altitude groups, the
Lima control subjects were compared to the high altitude
groups, while in Lima.
Gene expression data were log transformed to obtain sym-
metric distributions for analysis and for graphical pur-
poses. For comparing means of more than two groups at
high altitude and at sea level, ANOVA test was run. The
gene expression variables that best predicted the CMS
classification of 10 Cerro de Pasco fathers with CMS and
10 Cerro de Pasco control-fathers were obtained by con-
sidering 1 and 2 variable models in stepwise and "all sub-
sets" logistic regression, sensitivity and specificity using
median cut scores, and the effect sizes (standardized beta)
in univariate and bivariate logistic regressions at sea level
(Lima) and at altitude (Cerro de Pasco, 4338 m). The best
two gene model using expressions at sea level (Lima) in
the fathers was LDHA based on sensitivity (90%) and spe-
cificity (100%) and PDP2 based on effect size (standard-
ized beta) in logistic regression [11]. Since lactate
dehydrogenase A (LDHA) was not measured at high alti-
tude (Cerro), PDK3 was used, based on having the highest
correlation with LDHA at Lima. The "niche" scatterplots
show the two predictor genes selected as best at each alti-
tude for the children.
All the analyses were run using SAS 9.1 and SPSS 13.0.
Results
Children from all three groups were comparable in
weight, height, blood pressure, respiratory rate, and heart
rate. Sea level children were somewhat younger than
those from high altitude (Table 1). As expected, haemo-
globin and haematocrit were significantly lower and SaO2
significantly higher in sea level children than in any of the
high altitude groups (Table 1).
HIF-regulated genes
The impact table shows the predicting power of specific
hypoxia-related genes on CMS in the fathers of Andean
children (Table 2). Note that the genes were assayed in
children, whereas the CMS scores were those of their
fathers.
In univariate linear regression model, HPH3 (assayed in
the children) was found to be the most significant predic-
tor of CMS-sc in the fathers (Table 2, in bold font). Adjust-
ing for HPH3 eliminates the impact of the other genes on
the CMS-sc (columns "adjusted for HPH3"). However,
adjusting HPH3 for each of the remaining genes, assayed
here, strengthens the impact of HPH3 (columns "adjustedBMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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HPH3"). This supports the importance of HPH3 as meas-
ured in the children, in predicting CMS-sc of their fathers
at altitude. However, in Lima (normoxia) in the univari-
ate linear regression model, LDHA was found to be the
most significant predictor of CMS-scores of the fathers.
But, because there were no significant differences in
expression levels in the 3 children's groups at Lima, the
impact of LDHA was weakened (columns "adjusted
LDHA") in normoxia.
Hypoxia Inducible Factor 3 is a prolyl hydroxylase (HPH),
an enzyme that allows oxygen tension to control HIF-
alpha protein levels; LDHA is involved in "buffering"
pyruvate by reversibly converting to lactate. It favors for-
mation of lactate, when pyruvate builds up too quickly or
when there is a block in pyruvate metabolism due to pyru-
vate dehydrogenase inhibition or lack of sufficient oxy-
gen.
Genes directly regulated by HIF showed lower expression
levels (EPO, HPH1, HIF-1 alpha, HIF-1 beta, HIF-2 alpha,
HIF-3 alpha, HPH1, HPH3, and EPOR) in the sea level
children group than in both of the high altitude groups
when their samples were collected at high altitude. By
contrast, all genes were expressed at similar levels for all 3
groups at sea level, except for EPOR, which was higher in
HA controls (Table 3). Gene expression did not differ sig-
nificantly between HA controls and HA children of fathers
with CMS while they were studied at high altitude (Table
3).
Genes involved in glycolysis and in the Krebs cycle
Gene expression of PDK1, PDK2, PDK3, PDK4, PDP1,
PDP2, PDHE1A1, and GADPH was higher in sea level
children than in their high altitude counterparts when
they were examined in their native high altitude environ-
ment (Table 4). Whereas, at sea level, children of fathers
with CMS showed similar gene expression levels to HA
controls and sea level children (Table 4).
Niche graphs
The "niche" scatter plots illustrate the two gene expression
levels that best predicted "CMS parenthood" in the chil-
dren (HPH3 and PDK1). This expression was significantly
lower at altitude than at sea level (Fig. 1). Moreover, the
children of parents with CMS had even lower expression
levels of these genes than HA control children; and they
were clearly separated by the discriminator line con-
structed based on discrimination of the two groups by
logistic regression (Fig. 1). The control SL children, at sea
level in Lima, have still higher expression levels for HPH3
and PDK1 (Fig. 1). Immediately after descent to sea level,
normoxia, all highland children had similar expression
levels of HPH3 and PDK1 (Fig. 2).
Discussion
Chronic mountain sickness causes enormous social prob-
lems in the high Andes such as early death of bread win-
ners in usually large families and excessive burdens on
already meager health services in the highlands [19]. To
anticipate the occurrence of CMS and initiate preventive
treatment may contribute to the well being of large num-
bers of villagers in the Andes and Altiplano. These social
concerns have underscored our efforts to determine possi-
ble predictors of this disease.
We show, for the first time, using molecular signatures,
defined as distinct patterns of gene expression, that chil-
dren of fathers with CMS, who themselves show no signs
of ill health, have distinguishing molecular signatures in
their native highland environment (Fig. 1); a possible
biomarker of the disease. By contrast, when hypoxia is
removed by short sea level sojourn, the molecular signa-
tures in these same highland children are indistinguisha-
ble from sea level children, (Fig. 2). We emphasize that no
clinical evidence of CMS was detectable in the children,
neither in their native highland village, nor during their
short stay in Lima, Peru. The later occurrence of CMS, usu-
ally a disease of older men and post-menopausal women,
Table 1: Demographic and clinical characteristics of children by groups
SL children HA control children CMS children
Age (yrs) 9.91(3.15)* 13.05(3.35) 12.24(2.65)
Weight (kg) 38.45(13.53) 37.98(10.49) 35.87(10.67)
Height (cm) 132.45(20.41) 140.60(14.37) 140.70(17.46)
Hb(g/dL) 12.74(0.84)** 15.44(1.02) 15.69(1.42)
Hct (%) 38.73(2.52)** 47.08(3.09) 47.45(4.29)
SaO2 98.95(2.11)* 94.75(5.56) 94.30(6.34)
HR (beats/min) 74.30(12.06) 69.35(10.82) 75.05(18.22)
RR (resp/min) 23.50(5.46) 22.50(4.35) 23.80(5.06)
SBP (mmHg) 95.00(13.95) 97.00(8.01) 92.00(8.94)
DBP (mmHg) 57.75(8.66) 58.00(8.94) 57.50(7.69)
SL: sea level; HA: high altitude; CMS: children from subjects affected by CMS. Difference between groups (ANOVA): *p < 0.05; **p < 0.001BMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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may, therefore, be predictable during childhood, with
important public health implications.
High altitude children had low expression of HPH3 and
PDK1 in their native environment. Whereas HPH3 allows
oxygen tension to control HIF-alpha protein levels; PDK1
is an enzyme involved in "aerobic glycolysis" (the War-
burg effect). This enzyme supports a metabolic pattern
seen in many hypoxia adapted tissues. Low expression of
these two enzymes was a characteristic feature of children
fathered by CMS patients when studied in their native
ambient hypoxia (Fig. 1). But the removal of ambient
hypoxia for 1 hour in Lima was sufficient to increase
expression of these genes to levels comparable to those
found in children of sea level fathers who have no altitude
ancestry (Fig. 2).
Table 2: Impact table to show the predicting power of specific hypoxia-related genes on CMS (CMS-score ≥ 12) in the fathers of 
Andean children
In Children Adjust for HPH3 Adjust HPH3
At Cerro STB P Cerro STB P Cerro STB P
log_EPO -0.07 0.79 log_EPO -0.36 0.32 log_HPH3 0.88 0.05
log_HPH1 0.02 0.94 log_HPH1 0.06 0.84 log_HPH3 0.75 0.07
log_HPH2 0.21 0.44 log_HPH2 0.20 0.53 log_HPH3 0.75 0.07
log_HPH3 0.74 0.07
log_VEGFC -0.05 0.85 log_VEGFC -0.38 0.27 log_HPH3 0.96 0.05
log_PDK1 -0.30 0.38 log_PDK1 -2.69 0.18 log_HPH3 2.82 0.08
log_PDP1 0.16 0.55 log_PDP1 -0.36 0.38 log_HPH3 1.00 0.06
log_HIF1A 0.67 0.07 log_HIF1A 0.51 0.19 log_HPH3 0.61 0.17
log_HIF1B -0.43 0.24 log_HIF1B -1.28 0.07 log_HPH3 1.84 0.08
log_HIF2A 0.61 0.08 log_HIF2A 0.78 0.13 log_HPH3 1.00 0.11
log_HIF3A 0.01 0.98 log_HIF3A -0.17 0.62 log_HPH3 0.77 0.06
log_POK2 0.02 0.94 log_POK2 -0.20 0.53 log_HPH3 0.80 0.06
log_PDP2 0.06 0.83 log_PDP2 -0.18 0.58 log_HPH3 0.80 0.06
log_PDK3 -0.37 0.26 log_PDK3 -0.91 0.04 log_HPH3 1.39 0.04
log_PDK4 -0.21 0.45 log_PDK4 -0.20 0.51 log_HPH3 0.73 0.07
log_PDHE1A1 -0.25 0.39 log_PDHE1A1 -0.98 0.06 log_HPH3 1.54 0.05
log_GADPH -0.20 0.48 log_GADPH -1.01 0.08 log_HPH3 1.62 0.05
log_EPOR 0.24 0.40 log_EPOR -0.38 0.43 log_HPH3 1.02 0.07
log_GLUT1 -0.15 0.59 log_GLUT1 -0.53 0.15 log_HPH3 1.05 0.05
log_LDHA missing
log_CATD missing
Adjust for LDHA Adjust LDHA
At Lima Lima STB P Lima STB P
log_EPO -0.13 0.61 log_EPO 0.13 0.70 log_LDHA -0.64 0.09
log_HPH1 0.29 0.28 log_HPH1 0.45 0.20 log_LDHA -0.69 0.07
log_HPH2 -0.38 0.18 log_HPH2 -0.20 0.51 log_LDHA -0.50 0.16
log_HPH3 0.12 0.67 log_HPH3 0.40 0.34 log_LDHA -0.84 0.08
log_VEGFC missing log_VEGFC
log_PDK1 -0.27 0.34 log_PDK1 0.17 0.68 log_LDHA -0.68 0.10
log_PDP1 -0.51 0.09 log_PDP1 -0.28 0.44 log_LDHA -0.40 0.31
log_HIF1A 0.18 0.50 log_HIF1A 0.48 0.20 log_LDHA -0.76 0.05
log_HIF1B -0.26 0.32 log_HIF1B 0.11 0.76 log_LDHA -0.65 0.12
log_HIF2A -0.21 0.45 log_HIF2A 0.30 0.47 log_LDHA -0.69 0.07
log_HIF3A 0.29 0.28 log_HIF3A 0.45 0.20 log_LDHA -0.77 0.08
log_POK2 -0.33 0.24 log_POK2 -0.16 0.64 log_LDHA -0.52 0.14
log_PDP2 -0.41 0.17 log_PDP2 -0.01 0.99 log_LDHA -0.57 0.25
log_PDK3 -0.30 0.27 log_PDK3 0.00 1.00 log_LDHA -0.58 0.14
log_PDK4 -0.32 0.27 log_PDK4 -0.37 0.31 log_LDHA -0.61 0.09
log_PDHE1A1 -0.27 0.31 log_PDHE1A1 0.68 0.24 log_LDHA -1.20 0.07
log_GADPH 0.12 0.67 log_GADPH 0.40 0.34 log_LDHA -0.84 0.08
log_EPOR 0.33 0.25 log_EPOR 1.14 0.08 log_LDHA -1.21 0.03
log_GLUT1 missing
log_LDHA -0.58 0.09
log_CATD -0.46 0.13 log_CATD -0.09 0.85 log_LDHA -0.51 0.30BMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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How could HPH3 and PDK1 expression levels predict
chronic mountain sickness later in life? Hypoxia, such as
is inescapable in the highlands, leads to the formation of
free radicals and oxidants [20]. These chemical species,
by-products of mitochondrial metabolism, include the
superoxides (O2
-), peroxides (H2O2) and hydroxyl radi-
cals (OH-) are collectively designated as reactive oxygen
species (ROS) [21]. However, these molecules are also
crucial for the maintenance of homeostasis, especially in
the face of hypoxia. The ROS abundantly formed during
hypoxia modify proteins, allowing them to detect oxi-
dants and maintain homeostasis, as has recently been
shown for the guanosine 3',5'-monophosphate cGMP-
dependent protein kinase PKG 1α isoform, a direct perox-
ide (H2O2) sensor [22]. In addition, deficient peripheral
PDK1 and HPH3 mRNA expression at altitude in children
of CMS parents attests to a defective coupling between gly-
colysis and mitochondria TCA cycle, which may be a key
mechanism/biomarker for adult CMS.
Recent studies on hypoxic cells identified critical adapta-
tions that could prevent hypoxia-induced increases in
ROS production and thus forestall ROS damage to cellular
proteins. Amongst those adaptations is increased expres-
sion of PDK1 [17], and HPH3 may act in a similar fash-
ion. Thus the childhood reduction of hypoxia-induced
ROS accumulation at altitude, by appropriate up-regula-
tion of PDK1 and HPH3, to levels we found in control
children, might prevent time induced accumulation of
ROS which ultimately may lead to the clinical develop-
ment of the CMS syndrome in the children fathered by
CMS patients.
The maintenance of homeostasis, the ability to maintain
a steady state in the face of hypoxic stress, is fundamental
to adaptation for life anywhere, including life in chronic
hypoxia. Failure to upregulate genes that help maintain
cellular homeostasis in hypoxia, as we found here, may
place these children at an evolutionary disadvantage. Not
surprisingly such disadvantage, if based on genetic differ-
ences, might be evident early in life.
Gene expression levels, as measured here, are the result of
many factors that act on the DNA sequence. Epigenetic
influences, a set of heritable DNA or protein changes not
involving DNA mutations, are known to affect gene
expression [23,24]. In addition, early environmental fac-
tors acting during embryonic, fetal, or early postnatal peri-
ods may also modify gene expression [12,16,23].
We must acknowledge some methodological constraints.
We studied our subjects in the field and thus strict labora-
tory procedures were usually unattainable. In addition,
although larger numbers of subjects in each study group
were desirable these could not be assembled because of
time limitations at altitude for sea level researchers and
Table 3: Expression of genes regulated by HIF, at high altitude and at sea level
CMS children at HA CMS children at SL HA control at HA HA controls at SL SL children
log EPO 0.042(0.029)* -1.979(0.189) 0.040(0.025) -1.939(0.177) -1.793(0.502)
log HIF-1 alpha -6.059(0.565)* -2.577(0.229) -6.647(0.453) -2.699(0.538) -2.491(0.657)
log HIF-1 beta -3.069(0.385)* 0.192(0.143) -2.865(0.200) 0.258(0.155) 0.191(0.252)
log HIF-2 alpha -3.763(0.369)* -1.183(0.172) -4.062(0.342) -1.086(0.376) -0.989(0.376)
log HIF-3 alpha -5.430(0.432)* -2.980(1.125) -5.422(0.225) -3.463(0.848) -2.963(0.844)
log HPH1 -0.245(2.880)* -2.980(1.125) -0.088(2.885) -3.463(0.848) -2.963(0.844)
log HPH2 1.063(2.352) 0.532(0.136) -0.149(2.357) 0.613(0.124) 0.447(0.207)
log HPH3 -5.545(0.673)* -3.351(1.528) -6.166(0.499) -3.646(1.431) -2.773(1.701)
log EPOr -2.981(0.340)* 0.127(0.159) -3.056(0.204) 0.026(0.217) -0.029(0.189)
Difference between groups (ANOVA): *p < 0.001
Table 4: Expression of genes involved in glycolisis, Krebs cycle, and related genes – at high altitude and at sea level
CMS children at HA CMS children in Lima HA control at HA HA controls at SL SL children
log PDK-1 -3.591(0.459)* 0.223(0.176) -3.419(0.149) 0.299(0.178) 0.253(0.243)
log PDK-2 -2.869(0.172)* 0.203(0.111) -2.858(0.167) 0.281(0.173) 0.171(0.240)
log PDK-3 -3.114(0.414)* 0.551(0.127) -2.918(0.206) 0.620(0.147) 0.446(0.222)
log PDK-4 -4.536(0.353)* -0.564(0.310) -4.409(0.387) -0.402(0.331) -0.833(0.368)
log PDP-1 -2.997(0.217)* 0.132(0.141) -3.019(0.237) 0.238(0.113) 0.030(0.214)
log PDP-2 -3.750(0.444)* -0.678(0.201) -3.776(0.147) -0.576(0.091) -0.604(0.196)
log PDHE1A1 -3.357(0.387)* 0.003(0.140) -3.193(0.308) 0.070(0.154) 0.001(0.206)
log GADPH -1.835(0.304)** -3.351(1.528) -1.744(0.183) -3.646(1.431) -2.773(1.701)
Difference between groups (ANOVA): *p < 0.001; **p < 0.005BMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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especially because molecular studies were combined with
clinical evaluations in the same individuals. The research
station of the Universidad Peruana Cayetano Heredia in
Cerro de Pasco, Peru maintains a list of CMS patients and
controls. We used this list to recruit our subjects in Peru.
Because women are protected from CMS until the meno-
pause, the list contains mainly men. Thus, the results of
our earlier studies had unavoidable gender bias. Subse-
quently, the gender bias imposed on us previously con-
strained our selection. Therefore we used fathers only for
CMS scoring purposes.
In previous field studies we found that exposure to 1 hour
of normoxia at sea level, or 1 hour of hyperoxia at the res-
ident altitude of highlanders [11] was sufficient to change
gene expression in white cells [25], which predicated the
short exposure times of highland children in Lima.
Conclusion
We designed this study to measure gene expression that
may predict the later occurrence of CMS. Regardless of
how such biomarkers may have been induced, by epige-
netic influences, evolutionary pressures or failure to
Niche (scatter) plots of gene expression levels in children that predict the CMS status of their fathers Figure 1
Niche (scatter) plots of gene expression levels in children that predict the CMS status of their fathers.BMC Pediatrics 2008, 8:47 http://www.biomedcentral.com/1471-2431/8/47
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respond to hypoxic stress, our findings point to an impor-
tant role of particular genetic signatures in highland chil-
dren for the later development of CMS. We anticipate that
use of such biomarkers in planning for health promotion
and social justice in the highlands of Peru might benefit
the future of highland children in the Andes.
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